CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX)

Historical Holders from Q2 2015 to Q3 2025

Symbol
CDTX on Nasdaq
Type / Class
Equity / Stock
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
11,162
Holdings value
$1,068,585
% of all portfolios
0%
Number of holders
5
Number of buys
4
Number of sells
-1
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 11,162 $1,068,585 +$479,120 $95.76 5
2025 Q2 6,156 $299,872 +$299,872 $55.36 2
2024 Q3 0 $0 -$3,680 0
2024 Q2 4,000 $3,680 -$20,275,391 $0.9200 1
2024 Q1 22,051,850 $20,286,716 -$802,406 $0.9200 48
2023 Q4 23,179,993 $18,404,978 -$797,649 $0.7940 50
2023 Q3 24,074,750 $22,682,521 -$2,155,065 $0.9422 52
2023 Q2 26,255,377 $29,668,820 -$1,145,999 $1.13 52
2023 Q1 27,108,727 $34,423,224 +$1,359,564 $1.27 52
2022 Q4 26,649,589 $20,150,770 -$151,817 $0.7563 40
2022 Q3 27,071,246 $17,059,222 -$37,085 $0.6280 38
2022 Q2 27,212,375 $13,293,172 -$1,660,177 $0.4884 40
2022 Q1 30,311,243 $25,235,294 -$985,119 $0.8323 40
2021 Q4 31,078,404 $39,465,681 +$12,358,080 $1.27 48
2021 Q3 18,813,420 $42,135,590 -$2,372,049 $2.24 48
2021 Q2 20,047,956 $40,494,347 -$3,279,287 $2.02 54
2021 Q1 21,295,119 $56,643,120 -$5,972,493 $2.66 62
2020 Q4 24,265,251 $48,528,100 -$6,740,591 $2.00 62
2020 Q3 26,716,179 $76,160,126 +$4,210,544 $2.85 66
2020 Q2 25,106,069 $92,697,628 +$12,171,464 $3.69 64
2020 Q1 22,439,168 $55,624,774 +$14,473,395 $2.48 51
2019 Q4 16,489,227 $63,315,008 +$3,476,610 $3.84 51
2019 Q3 14,467,951 $28,865,006 -$2,400,388 $2.00 35
2019 Q2 15,848,616 $26,586,005 +$2,145,412 $1.68 43
2019 Q1 16,070,639 $42,548,008 -$4,202,884 $2.65 49
2018 Q4 17,674,910 $41,473,007 -$7,058,607 $2.35 49
2018 Q3 18,574,521 $81,749,013 -$2,220,465 $4.40 60
2018 Q2 19,059,589 $99,106,188 +$23,669,420 $5.20 58
2018 Q1 13,263,119 $53,050,412 -$8,595,248 $4.00 59
2017 Q4 14,927,520 $101,510,700 +$13,534,074 $6.80 49
2017 Q3 11,216,419 $90,850,834 +$922,705 $8.10 42
2017 Q2 11,143,670 $83,576,773 -$2,424,703 $7.50 55
2017 Q1 11,449,003 $89,298,264 +$3,842,220 $7.80 52
2016 Q4 11,395,122 $118,510,438 +$22,410,725 $10.40 58
2016 Q3 7,878,814 $90,208,154 -$2,740,376 $11.45 51
2016 Q2 8,168,686 $84,214,036 -$7,196,319 $10.31 55
2016 Q1 8,818,138 $111,986,000 -$1,571,585 $12.70 43
2015 Q4 8,936,177 $153,339,825 +$3,169,598 $17.16 43
2015 Q3 7,599,724 $96,664,656 +$21,115,100 $12.72 45
2015 Q2 5,937,679 $83,245,564 +$83,245,564 $14.02 44